WHAT'S NEW WITH METHICILLIN-RESISTANT STAPHYLOCOCCI

摘要

Methicillin-resistant Staphylococcus spp (MRS) continue to pose significant challenges to both the veterinary and human healthcare systems. With their inherent resistance to all beta-lactam antimicrobials (including carbapenems) and frequent acquisition of other resistance genes, treatment options may be very limited. Many different staphylococcal species exist, with the coagulase-positive S. aureus, S. pseudintermedius and S. schleiferi coagulans most often involved in disease. A comprehensive review of the epidemiology, clinical relevance, diagnosis, treatment and prevention of MR-staphylococcal infections is well beyond the scope of these proceedings. However, some interesting or important new developments that may be relevant to the veterinary internist are described below.